Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/22/2015 07/23/2015 07/24/2015 07/27/2015 07/28/2015 Date
131.02(c) 130.85(c) 125.5(c) 123.23(c) 128.3 Last
978 521 870 010 1 362 793 2 042 296 1 941 109 Volume
+0.04% -0.13% -4.09% -1.81% +4.11% Change
More quotes
Financials ($)
Sales 2015 959 M
EBIT 2015 -364 M
Net income 2015 -542 M
Finance 2015 479 M
Yield 2015 -
Sales 2016 2 669 M
EBIT 2016 1 094 M
Net income 2016 842 M
Finance 2016 1 556 M
Yield 2016 -
PER 2015 -
PER 2016 37,35
EV / Sales 2015 30,8x
EV / Sales 2016 10,7x
Capitalization 30 038 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
07/22 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2015 Financial Results on Ju..
07/15 VERTEX PHARMACEUTICALS : FDA Approves ORKAMBI™ lumacaftor/ivacaftor - the ..
07/15 VERTEX PHARMACEUTICALS : Study Data from Vertex Pharmaceuticals Inc. Provide New..
07/15 VERTEX PHARMACEUTICALS : FDA Greenlights Vertex' ORKAMBI Cystic Fibrosis Medicin..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2015 Financial Results on Ju..
07/08 VERTEX PHARMACEUTICALS : Reports Summarize Pharmaceutical and Biomedical Analysi..
07/08 Cerulean Pharma Appoints Stuart A. Arbuckle to Board of Directors
07/08 VERTEX PHARMACEUTICALS : FDA Greenlights Vertex' ORKAMBI Cystic Fibrosis Medicin..
More news
Sector news : Biopharmaceuticals
04:03p GILEAD SCIENCES : Announces Third Quarter 2015 Dividend
04:02p GILEAD SCIENCES : Announces Second Quarter 2015 Financial Results
03:38p PFIZER : raises forecast for 2015
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/24 PREMARKET BIOTECH DIGEST : The PCSK9 Race, AbbVie Earnings, Inotek Jumps 200%
07/21 A Few Key Points I Am Watching For From Gilead Sciences
07/21 PREMARKET BIOTECH DIGEST : Sanofi And Cholesterol, Novartis Misses, Alzheimer's ..
07/16 PREMARKET BIOTECH DIGEST : Lure Of Startups, Geron's Short Squeeze, New ODDs
07/15 An Analysis Of Intercept Pharma, An Innovator In Serious Liver Diseases With ..


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions